PMGC Holdings Inc. (NASDAQ:ELAB) Short Interest Down 39.6% in August

PMGC Holdings Inc. (NASDAQ:ELAB) was the target of a large decline in short interest during the month of August. As of August 14th, there was short interest totaling 265,900 shares, a decline of 39.6% from the July 30th total of 440,372 shares. Based on an average trading volume of 216,457 shares, the days-to-cover ratio is presently 1.2 days. Currently, 32.8% of the shares of the stock are short sold.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of PMGC in a report on Friday, June 26th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has an average rating of “Sell”.

PMGC Price Performance

Shares of NASDAQ:ELAB traded down $0.09 on Monday, reaching $5.22. The company’s stock had a trading volume of 8,051 shares, compared to its average volume of 400,204. PMGC has a 52-week low of $5.06 and a 52-week high of $2,671.20. The company has a market cap of $4.23 million, a P/E ratio of -0.00 and a beta of -0.25. The company has a 50-day simple moving average of $9.77 and a 200 day simple moving average of $28.65. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.30 and a current ratio of 1.36.

PMGC Company Profile

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.